Actively Recruiting
A Long Term Follow-up Study of TScan TCR-T Products
Led by TScan Therapeutics, Inc. · Updated on 2025-09-10
1000
Participants Needed
2
Research Sites
781 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.
CONDITIONS
Official Title
A Long Term Follow-up Study of TScan TCR-T Products
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants who received a TCR-T cellular therapy in a clinical study sponsored by TScan Therapeutics.
- Signed informed consent.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
City of Hope
Duarte, California, United States, 91010
Actively Recruiting
2
Mount Sinai
New York, New York, United States, 10029-6696
Actively Recruiting
Research Team
M
Madhavi Desai
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here